This year’s Nobel Prize in Physiology or Medicine has been awarded to biochemist Katalin Karikó and immunologist Drew Weissman for discoveries that enabled the development of mRNA vaccines against COVID-19.
China became the first country to approve a needle-free, inhaled version of a Covid-19 vaccine. The vaccine is similar to those developed by AstraZeneca Plc and Johnson & Johnson.
Cases of COVID-19 are extremely rare among people who are fully vaccinated, according to a U.S. data analysis. COVID- 19 breakthroughs occur at the rate of less than 0.008 % of fully vaccinated people.
A handful of countries representing just 16 percent of the world's population have snapped up more than half of the available COVID-19 vaccines. If the rich world continues to hoard vaccines, the pandemic will drag on for long.
From the rapid development of vaccines for Covid-19 to the stunning collection of an asteroid sample, these were the biggest science moments of the year.
U.S. firm Moderna said that Phase 3 stage analysis suggested its coronavirus vaccine could prevent COVID-19. The news comes a week after Pfizer and German drug-maker BioNTech announced a vaccine of their own.
A U.S. scientific team has successfully redesigned a key protein from the coronavirus, and the modification could enable much faster and more stable production of vaccines worldwide.
An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was generally well tolerated and prompted antibody activity.
The first COVID-19 vaccine to reach phase 1 clinical trial has been found to be safe, well-tolerated, and able to generate an immune response against SARS-CoV-2 in humans, according to new research.
About 35 companies and academic institutions are racing to create Covid-19 vaccine.
If it seems that your news feed has been flooded with nerve-wracking updates on the COVID-19 outbreaks, have no fear—there are also plenty of positive updates on the pandemic as well.
U.S biophysicists have used the IBM-built supercomputer SUMMIT to sift through thousands of molecules and find potential compounds that could be used as a new drug against the coronavirus responsible for the current COVID-19 pandemic.
